Victory RS International has several appealing traits that make it a solid non-US core equity offering. Analyst coverage of the strategy has been initiated with Above Average People and Process ratings.
Victory RS International A GUBGX
- NAV / 1-Day Return 16.21 / −0.98 %
- Total Assets 440.8 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.130%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.63%
- Turnover 24%
USD | NAV as of Oct 03, 2024 | 1-Day Return as of Oct 03, 2024, 10:16 PM GMT+0
Morningstar’s Analysis GUBGX
Will GUBGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk A/S Class B | 4.34 | 17.8 Mil | Healthcare |
Novartis AG Registered Shares | 2.73 | 11.2 Mil | Healthcare |
Roche Holding AG | 2.52 | 10.3 Mil | Healthcare |
Nestle SA | 2.48 | 10.1 Mil | Consumer Defensive |
Toyota Motor Corp | 2.32 | 9.5 Mil | Consumer Cyclical |
SAP SE | 2.29 | 9.4 Mil | Technology |
Shell PLC | 2.18 | 8.9 Mil | Energy |
L'Oreal SA | 2.12 | 8.7 Mil | Consumer Defensive |
Banco Bilbao Vizcaya Argentaria SA | 2.11 | 8.6 Mil | Financial Services |
BHP Group Ltd | 2.11 | 8.6 Mil | Basic Materials |